Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul S Dalal

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of Leukocyte Biology|May 15, 2014
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancerRahul S Dalal, Steven F Moss
Therapeutic Advances in Gastroenterology|October 8, 2025
A targeted review of clinical outcomes of advanced IBD therapies in Latin AmericaIeshaan S Kumar, Rahul S Dalal
Current Opinion in Gastroenterology|March 3, 2021
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel diseaseRahul S Dalal, Jessica R Allegretti
Journal of Clinical Gastroenterology|September 26, 2022
Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative ColitisRahul S Dalal, Jennifer Mitri, Hannah Goodrick, et al.
Digestive Diseases and Sciences|April 13, 2022
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative ColitisRahul S Dalal, Emma L McClure, Jenna Marcus, et al.
Clinical Rheumatology|July 10, 2023
Activity of axial spondyloarthritis after one year of anti-tumor necrosis factor therapy among patients with inflammatory bowel diseasesRahul S Dalal, Joerg Ermann, Alexander Carlin, et al.
Rhode Island Medical Journal (2013)|August 2, 2014
Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapyRahul S Dalal, Mark P LeGolvan, Dariusz R Stachurski, et al.
Inflammatory Bowel Diseases|November 4, 2020
Predictors of Ustekinumab Failure in Crohn's Disease After Dose IntensificationRahul S Dalal, Cheikh Njie, Jenna Marcus, et al.
Inflammatory Bowel Diseases|May 1, 2019
Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching HospitalsRahul S Dalal, Ravy K Vajravelu, James D Lewis, et al.
The American Journal of Gastroenterology|March 12, 2024
One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort StudyRahul S Dalal, Govind Kallumkal, Heidy J Cabral, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|May 15, 2014
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancerRahul S Dalal, Steven F Moss
Therapeutic Advances in Gastroenterology|October 8, 2025
A targeted review of clinical outcomes of advanced IBD therapies in Latin AmericaIeshaan S Kumar, Rahul S Dalal
Current Opinion in Gastroenterology|March 3, 2021
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel diseaseRahul S Dalal, Jessica R Allegretti
Journal of Clinical Gastroenterology|September 26, 2022
Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative ColitisRahul S Dalal, Jennifer Mitri, Hannah Goodrick, et al.
Digestive Diseases and Sciences|April 13, 2022
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative ColitisRahul S Dalal, Emma L McClure, Jenna Marcus, et al.
Clinical Rheumatology|July 10, 2023
Activity of axial spondyloarthritis after one year of anti-tumor necrosis factor therapy among patients with inflammatory bowel diseasesRahul S Dalal, Joerg Ermann, Alexander Carlin, et al.
Rhode Island Medical Journal (2013)|August 2, 2014
Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapyRahul S Dalal, Mark P LeGolvan, Dariusz R Stachurski, et al.
Inflammatory Bowel Diseases|November 4, 2020
Predictors of Ustekinumab Failure in Crohn's Disease After Dose IntensificationRahul S Dalal, Cheikh Njie, Jenna Marcus, et al.
Inflammatory Bowel Diseases|May 1, 2019
Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching HospitalsRahul S Dalal, Ravy K Vajravelu, James D Lewis, et al.
The American Journal of Gastroenterology|March 12, 2024
One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort StudyRahul S Dalal, Govind Kallumkal, Heidy J Cabral, et al.
Pageof 5